{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:09:56Z","timestamp":1789992596161,"version":"4.0.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["RT-02040"],"award-info":[{"award-number":["RT-02040"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Patient-specific induced pluripotent stem cells (iPSCs) hold great promise for many applications, including disease modeling to elucidate mechanisms involved in disease pathogenesis, drug screening, and ultimately regenerative medicine therapies. A frequently used starting source of cells for reprogramming has been dermal fibroblasts isolated from skin biopsies. However, numerous repositories containing lymphoblastoid cell lines (LCLs) generated from a wide array of patients also exist in abundance. To date, this rich bioresource has been severely underused for iPSC generation. We first attempted to create iPSCs from LCLs using two existing methods but were unsuccessful. Here we report a new and more reliable method for LCL reprogramming using episomal plasmids expressing pluripotency factors and p53 shRNA in combination with small molecules. The LCL-derived iPSCs (LCL-iPSCs) exhibited identical characteristics to fibroblast-derived iPSCs (fib-iPSCs), wherein they retained their genotype, exhibited a normal pluripotency profile, and readily differentiated into all three germ-layer cell types. As expected, they also maintained rearrangement of the heavy chain immunoglobulin locus. Importantly, we also show efficient iPSC generation from LCLs of patients with spinal muscular atrophy and inflammatory bowel disease. These LCL-iPSCs retained the disease mutation and could differentiate into neurons, spinal motor neurons, and intestinal organoids, all of which were virtually indistinguishable from differentiated cells derived from fib-iPSCs. This method for reliably deriving iPSCs from patient LCLs paves the way for using invaluable worldwide LCL repositories to generate new human iPSC lines, thus providing an enormous bioresource for disease modeling, drug discovery, and regenerative medicine applications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5966\/sctm.2014-0121","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T06:57:09Z","timestamp":1412837829000},"page":"1429-1434","source":"Crossref","is-referenced-by-count":82,"title":["Reliable Generation of Induced Pluripotent Stem Cells From Human Lymphoblastoid Cell Lines"],"prefix":"10.1093","volume":"3","author":[{"given":"Robert","family":"Barrett","sequence":"first","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Ornelas","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Yeager","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berhan","family":"Mandefro","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Sahabian","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Lenaeus","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan R.","family":"Targan","sequence":"additional","affiliation":[{"name":"F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive N.","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Sareen","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,8]]},"reference":[{"key":"2021122709524461100_R1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10761","article-title":"The promise of induced pluripotent stem cells in research and therapy","volume":"481","author":"Robinton","year":"2012","journal-title":"Nature"},{"key":"2021122709524461100_R2","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1093\/emboj\/20.19.5453","article-title":"Design and development of a catalytic ribonucleoprotein","volume":"20","author":"Atsumi","year":"2001","journal-title":"EMBO J"},{"key":"2021122709524461100_R3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes","volume":"11","author":"HD iPSC Consortium","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2021122709524461100_R4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"2021122709524461100_R5","doi-asserted-by":"crossref","first-page":"e39113","DOI":"10.1371\/journal.pone.0039113","article-title":"Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy","volume":"7","author":"Sareen","year":"2012","journal-title":"PLoS One"},{"key":"2021122709524461100_R6","doi-asserted-by":"crossref","first-page":"208ra149","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021122709524461100_R7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"2021122709524461100_R8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2021122709524461100_R9","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jnr.22000","article-title":"Utility of lymphoblastoid cell lines","volume":"87","author":"Sie","year":"2009","journal-title":"J Neurosci Res"},{"key":"2021122709524461100_R10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/pgs.11.121","article-title":"Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation","volume":"13","author":"Wheeler","year":"2012","journal-title":"Pharmacogenomics"},{"key":"2021122709524461100_R11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2011-03-340620","article-title":"Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"2021122709524461100_R12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2011-01-332064","article-title":"Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells","volume":"118","author":"Rajesh","year":"2011","journal-title":"Blood"},{"key":"2021122709524461100_R13","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/jcb.24183","article-title":"Assessing iPSC reprogramming methods for their suitability in translational medicine","volume":"113","author":"Rao","year":"2012","journal-title":"J Cell Biochem"},{"key":"2021122709524461100_R14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nmeth.1580","article-title":"A bioinformatic assay for pluripotency in human cells","volume":"8","author":"M\u00fcller","year":"2011","journal-title":"Nat Methods"},{"key":"2021122709524461100_R15","doi-asserted-by":"crossref","first-page":"14188","DOI":"10.1073\/pnas.0605985103","article-title":"Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes","volume":"103","author":"Altmann","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122709524461100_R16","first-page":"509","article-title":"Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells","volume":"1","author":"Nissenbaum","year":"2013","journal-title":"Stem Cell Rev"},{"key":"2021122709524461100_R17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cell.2010.12.032","article-title":"Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines","volume":"144","author":"Bock","year":"2011","journal-title":"Cell"},{"key":"2021122709524461100_R18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: Why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"2021122709524461100_R19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(02)00835-8","article-title":"Directed differentiation of embryonic stem cells into motor neurons","volume":"110","author":"Wichterle","year":"2002","journal-title":"Cell"},{"key":"2021122709524461100_R20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nbt1063","article-title":"Specification of motoneurons from human embryonic stem cells","volume":"23","author":"Li","year":"2005","journal-title":"Nat Biotechnol"},{"key":"2021122709524461100_R21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt.2052","article-title":"Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells","volume":"29","author":"Kim","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2021122709524461100_R22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2011.06.007","article-title":"Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells","volume":"9","author":"Bar-Nur","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2021122709524461100_R23","doi-asserted-by":"crossref","first-page":"16196","DOI":"10.1073\/pnas.1202352109","article-title":"Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells","volume":"109","author":"Ruiz","year":"2012","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0121","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0121","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/3\/12\/1429\/41892913\/stcltm_3_12_1429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/3\/12\/1429\/41892913\/stcltm_3_12_1429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:48:41Z","timestamp":1642560521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/3\/12\/1429-1434\/6389859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,8]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,10,8]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2014-0121","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,10,8]]}}}